| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
13636370518 |
| Email: |
shyysw007@163.com |
| Products Intro: |
Product Name:Oleclumab (anti-CD73)
CAS:1803176-05-7
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:5mg Remarks:K10726
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Oleclumab
CAS:1803176-05-7
Purity:95% Package:100ug;500ug;1mg
|
| Company Name: |
Guangzhou Hongyuan Chemical Co.,Ltd
|
| Tel: |
15817493340 |
| Email: |
981810490@qq.com |
| Products Intro: |
Product Name:Oleclumab
CAS:1803176-05-7
Purity:95% Package:1mg;1g;100g
|
|
| | Oleclumab Basic information |
| Product Name: | Oleclumab | | Synonyms: | Oleclumab;Research Grade Oleclumab(DHD46601);Oleclumab (anti-CD73);Research Grade Oleclumab | | CAS: | 1803176-05-7 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Oleclumab Structure]() |
| | Oleclumab Chemical Properties |
| storage temp. | Store at -20°C | | form | Liquid | | color | Colorless to light yellow |
| | Oleclumab Usage And Synthesis |
| Uses | The CD73-antagonist antibody oleclumab inhibits cell surface-exposed CD73 and is currently undergoing clinical testing for cancer immunotherapy. | | in vivo | Oleclumab (10 mg/kg; ip; every 3 days for 4 doses) increases the proportion of activated CD8+ lymphocyte populations in the mouse Balb/c syngeneic CT26 colon cancer tumor model. And Oleclumab significantly inhibits tumor growth[2].
| Animal Model: | Murine, Balb/c, syngeneic CT26 colon carcinoma tumor model[2] | | Dosage: | 10 mg/kg | | Administration: | ip; 2 time per week, for 2 weeks | | Result: | Inhibited tumor growth by 50% or greater from study day 7 to study day 16 when compared with isotype control antibody-treated groups.
|
|
| | Oleclumab Preparation Products And Raw materials |
|